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CORONARY RISK FACTOR MODlFICAnON AFTER
CORONARY ARTERY BYPASS SURGERY
Abstract
Thisis a retrospective cohortstudythatexaminedwhethermajorcoronary
risk factorschangewhencomparedpreoperatively and 3 years
postoperativelyafter coronary artery bypass surgery. Preoperative coronary
risk factor data were obtained from a retrospective chart review. Threeyears
postoperative risk factor data were obtained by hospital attendance with
blood sampling, blood pressure measurements,weight and height
measurements, andansweringstandardquestionnaires. Resultsrevealeda
significantdecreasein total cholesterol and LDL~ a significant increase in
bloodpressureand body mass index,and a clinically significantchangein
smoking habits 3 years post surgery. Slightly more than half of the subjects
reportedan increasein exerciselevelseven thoughonly one fifthof them
attended cardiac rehabilitationprogram post surgery. Most subjects reported
strong social support in helping them to modify their coronary risk: factors.
Implicationsfor the currentstrategiesin the secondarypreventionof
coronary artery disease were examined.
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CORONARYRISK FACTOR MODIFICAnON
AFTER CORONARY ARTERYBYPASSSURGERY
Chapter1. Research Ouestion
Thisstudy wasperformed to determine whethermajorcoronary risk factors
changed 3 yearsaftercoronary artery bypasssurgery insubjects who
underwent the surgery between April 1, 1994 and March 31, 1995 in the
AvalonPeninsulaof Newfoundland, Canada. The coronaryriskfactors
assessedinthis studyinclude hyperlipidemia. hypertension, smoking status.
and obesity. A subjectivequestionnaire was also used to assess cardiac
rehabilitation attendance, exercise level, riskfactors counseling received, and
the degree of socia1 support availableto subjects post coronaryarterybypass
surgery.
1.1 Literature Search Strategiesand
Main search engines usedto perform theliterature search werePubMed on
the World Wide Web and WinSPIRS 2.1 (MedLine 00 Silver Planer ). Cross
checked seareb eogines were also osed.These includedHealtbstar, CINAHL,
andCochrane Library of Systematic Review.
Forthe initial reviewof coronary risk factorsandits relationship to ischemic
heart disease.search criteria syntax entered intothesearch engine was
"ischemicbeart disease" [MeSH] AND ("risk factors" OR "risk factor)
[MeSH]". Mctbodological term incloded "randomized cootrol trial" .
Further reviewofJiterature specifically in postCABGpopulations. additional
search criteria syntax used was"AND("after coronary artery bypass')AND
("control" OR "cootrolled" OR "modify" OR "modifies " OR "modifying"
OR "modification') AND english palAND hwnan [Ig]. Methodo logical term
wasaltered to "all studies" .
Search yieldeda totalof 146 studies. Finger indexing was used torefine
search related to theresearch question.
1.2 Review of Literature
Coronary heart disease (CHO) is the single largest cause of death in North
American men and women. Management of CHD includetreatmentwith
medicationsand the more invasive direct revascularizationof myocardium
with percutaneousmethodor with openchest operation. This openchest
operation is known as coronaryinterventioncoronary artery bypass graft
(CABG) surgery.
CABG surgery consists of the construction of new pathways (conduits)
between the aorta (or other major arteries) and segmentsof coronary arteries
beyond obstructive lesions for the purpose ofbrin ging blood to myocardium
made ischemic by these lesions. Since the early 1960's, reversed segments of
autologoussaphenousvein have beenused as the conduit in the surgery. In
1968 Greenused the left internalmammaryartery to bypass the left anterior
descendingcoronary artery, leading to better and longer graft patency rates.
Segmentsofradial artery, ann veins, allograft arteries, and veins and
synthetic tubes are now being used with variable results I .
CABG surgery has proved its superiorityover pharmacologicaltreatmentin
patients withseverecoronal)' artery disease2. Thisis basedon analysis of the
threelargest clinicaltrials of coronary arterybypass grafting,the Veterans
AdministrationCooperativeStudy of coronary artery surgery(VACS) " the
European CoronarySurgery Study(ECSS)', and the CoronaryArtery
SurgeryStudy (CASS) ' . The sicker the patient, (as gangedby relevant
measures of coronary disease andcardiovascular morbidity) themorelikely
CABGwill prolonglife. In summary, a CABG-related improvement in
survival is therefore morelikelyto occurif there is a leftventricular
dysfunction,multivessel disease,proximal coronary lesions(moremuscleis
threatenedby such lesions),high-gradelesions as determinedby angiography,
moresevereangina. or low-levelinducible ischemia.
Despitegoodsurvival ratesfrominitial CABG surgery, thenarrowing and
subsequent occlusionof thevenousgrafts, followedby recurrence of
symptoms andincreased inmortality, aremajor longterm problems 46.
Becausethesuccessratesof re-operationareless favourable thanafterfirst
operation7, interventions that slowthe progression of atheroscleroticchanges
in the grafts and nativecoronaryarteriesare essential.
Thereis clear epidemiologicalevidencethat coronaryarterydiseaserisk
factors are importantin the development of occlusion in bypassgrafts .
Factorsthat have been associatedwith the progression of atherosclerotic
plaquein bothgraftedand nativecoronaryvesselsincludehyperlipidemia,
smoking,hypertension. obesity. and lack of exercise.Numerousstudieshave
exploredthe relationship betweenthesecoronaryarteryrisk factorsand the
development of atherosclerosis aftercoronaryarterybypasssurgery. Among
these coronaryrisk factors,hyperlipidemia has been examinedthe most
extensively in the literature.
1.2.1 Hyperlipidemia andIschemic Heart Disease
Hyperlipidemia is a general term forelevated concentrations of any or
all of the lipids in the plasma,ineludinghypercholesterolemia and
hyperlipoproteinemia. Serum lipoprotein analysis allows measurement
of tota! cholesterol, triglycerides, and high-density lipoproteins (HDL).
Low-density lipoproteins(l.DL) concentration is thencalculated using
the fonnula LDL~ Tota!cholesterol - HDL- (Triglyceridel5).
Lowering serum lipidslevels hasbeen shownto decrease the risk of
recurrent coronaryevents andprocedures in patientswithCAD as well
as reduce theriskof developing CADinpeoplewith
hypercholesterolemia.
Campeauet aI., 1984• examined 82 patients angiographica1ly 10years
aftercoronary artery bypasssurgery. New lesionsdevelopedin81.7%
of patients - inthegrafts, thenativevessels,orboth. Plasma levels of
very-low-density lipoproteins (VLDLs)andlow-density lipoproteins
(LOLs) were significantly higher, and high-density lipoprotein (HDL)
levels were significantly lower in thosepatientswithnew disease 10
years after coronaryarterybypass surgery. Univariateanalysisshowed
that plasmacholesteroland triglyceridelevels wen: significantly higher
both at the timeof surgeryand at the Ie-year follow-upin thosewith
new lesions. These findings suggest that the developmentof
atherosclerosis affecting both the grafts and nativevessels may be
related to the plasma lipoprotein levels. However, the effectof plasma
lipoprotein levels on the progression of atherosclerosismay be
underestimated,sinceto be eligible for this restudy patientshad to
survive for 10 years after surgery. There was no significantassociation
between hypertension. cigarette smoking, and diabetes with the
developmentof new lesions. Thisis not surprising given the relatively
smallnumberof patientsstudied and the fact that these factorswere
treated as discrete. not continuous.variables.
A subsequentstudy, by the same author 9, examined1351 patientswho
had undergone bypass surgery I to II years before the intervention and
who had an LOL cholesterollevel between 130 and 175 mg per
deciliter (3.36 RUDOl/l and 4.53mmol/l)and at least one remaining
patent vein graft as seenon angiography. The study used a two-by-two
factorial designto assign patients to aggressiveor moderatetreatment
to lower WL cholesterol levels (with lovastatinand, ifneeded,
cholestyramine)and to treatmentwith warfarinor placebo.
Angiography wasrepeatedan average of 4.3 years afterbase line. The
primaryangiographicoutcome was the meanpercentageper patientof
grafts with a decrease of 0.6 romor morein lumen diameter. As
measured annually during the study period. the mean WL cholesterol
level of patients with aggressive treatment rangedfrom 93 to 97 mg per
deciliter(2.40 to 2.5I mmcl/l); with moderate treatment, the range was
from 132to 136 mgper deciliter (3.41 to 3.52 mmolll) (P<O.OOI). The
mean international nonnalizedratio (INR), a standardused to measure
coagulabilityof blood with highernumbersindicatingless coagulable
states, was1.4 in the warfaringroupand 1.1 in the placebogroup
(P<O.OOl ). The meanpercentageof grafts with progressionof
atherosclerosis was 27 percent for patientswhose WL cholesterol
levelwasloweredwithaggressivetreatment, and 39 percent for those
who received moderate treatment (p<O.OOl). There was no significant
difference in angiographic outcome between the warfarinand placebo
groups. The rate ofrevascularizationover four years was 29 percent
lower in the groupwhose WL cholesterollevelwas lowered
aggressivelythan in the group receiving moderate treatment (6.5
percent vs. 9.2 percent, P= 0.03). The study concluded that aggressive
lowering of LDL cholesterol levels 10below 100mg per deciliter (2.58
mmolA) reduced the progression of atherosclerosis in grafts. Low-dose
warfarindid not reduce the progression of atherosclerosis.
Althoughnot specific to the post CABG populations, there are
numerousother studies that have demonstrated significantreductions in
major cardiovascularevents (mortality, coronarymortality, total eHD
events, and stroke). which often begin 6 to 12 months after starting
lipid loweringtherapy with the statio class of drugs 10 11 12. The first
study to show an absolute reduction in total mortalityused a statin and
was called the Scandinavian SimvastarinSurvival Study (45) 13 14, It
was a randomized double blind studyof 35 to 70 years old subjects
(20% women)with a historyof acute MI or anginapectoris with high
total cholesterol treatedwith sunvastatin. Totalmortalitywas 8% in the
drug groupversus 12% in the placebo group . One hundredthirty five
patientswas the "number neededto treat" (NNT) for I year or 25
patients for 5 yearsto prevent1 death. Thisbenefitwas also seen in
womenand in thoseolder than60. Therewas decreasedcardiac
morbidity and needfor coronal)'arterybypassgraft (CABG) surgery
or angioplasty as foundby previousstudies. Therewas no differencein
non-cardiovascular mortality, indicatingsimvastatin was safe as well.
As for effectiveness in secondarypreventionwith a mildlyelevated
cholesterol,the Cholesteroland Recurrent Events(CARE) IS 16 11 was
also a randomizeddouble blind study looking at 4159 patients (mean
age, 59) with previousmyocardialinfarction (MI) over 5 years with a
cbolesterol< 240 mgldL (6.20 mmo\ll) (average total cholesterol,
209mgldL(5.40 mmol/lj). Pravastatin 40 mgld reduced risk of dying
fromCHO or having anotherMI by 24%,from 13.2% to 10.2%. All
causemortalitywas not decreased. In patients with LDL< 3.23 mmoL1
10
therewasnoreduction ineventssuggesting a threshold level. Subset
analysis of1 283 patients aged 65 to 75 yean; who had had MI and had
a plasma total cholesterol level less than6.2 mmolJl(240 mgldL) and a
lew-density lipoprotein cholesterol level of3 .0 to 4.5 mmopl, 5 year
eventrates of major coronary events (coronary death, nonfatal
myocardialinfarction,angioplasty,orbypass surgery) andstroke were
28.1%inplaceborecipients and19.7%inpravastatin recipients
(difference, 9010 [95%CI~ 4 to 13%]; relativeriskreduction. 32%;P<
0.001).
TheLong-termIntervention withPravastatin in Ischemic Disease
(LIPID) I I wasa similar secondaryprevention study,whichwasable to
showa drop inall causesof mortalityinpatients witha median
cholesterolof218 mgldL(5.63mmolJl).lt was a tandomized donhle
blindplacebo controlled study done in Australiaand New Zealand with
9014patients, predominantly male, witha median age of62 whowere
diagnosedafter hospitaldischarge witheitherMIor unstableangina.
After6 yean; the pravastatin group had an incidenceof CHD death of
II
6.4% comparedto 8.3% in the control group. The staringroupbad a
11% overall mortalitycomparedto 14.1% in the control group. All
cause mortalityand cardiovascular morbidity. and the need for
angicplasty, hospitalization,and more relevant to our study the need.
for CABG surgery. were all lowered.
The Veterans AffairsHigh-Density Lipoprotein Cholesterol
Intervention Trial Study (VA-lilT) Study 19 used gemfibrozil(1200
mgld) to treat men with confirmedClID whose primary lipid
abnormality was HDL (LDL < 3.62 mmolll,HDL < 1.03 mmoVl).
They were able to reduce absolute nonfatalMI or death from coronary
causes by 4.4% (21.7% to 17.3%) or a relative reduction of 22%.
Unlike previous studies using gemfibrozil there was no increased all
causes mortality.
In addition to these studies. a recent meta-analysis 20 indicates that
even modest lipid improvements over a short-term period(e.g.•2 to 5
tz
years) may reduce CHD events by up to 20% in patients 70 to 80 years
of age.
1.2.2 Smoking and Ischemic Heart Disease
Nwnerous studies since the 19505have shown that tobacco smokingis
a major atherosclerosisandCHDrisk factor. It is an even stronger
promoter of acute CHD events, which is the reason why marked
reductions in CHD eventsoccurearlyaftersmokingcessation,falling
to nearly the levels of control subjects within6 to 12 months. These
studies suggest that.comparedwith nonsmokers. those who conswne
20 or more cigarettesdaily have a twofold to threefold increase in total
coronary heart disease. Moreover, these effects depend on dose ;
consumptionof as fewas one to four cigarettes daily increases
coronary artery disease risk.
A study by Gerald et at.21 followedup 340 men who had undergone
CABG surgerywith repeat angiography. After5 years. 115 patients
13
were smokersand 225 were nonsmokers. The meannumberof grafts
per patientwere similarin the two groups.The studyfounddisease-
free grafts in 39% of the smokersand 52%of the nonsmokers. The
study suggestedthat men whocontinueto smoke are at significantly
greater risk (P < 0.05)of artherosclerosisand occlusionthan
nonsmokingmen.
Van DomburgRTetal. 22 studied 104) patientswho underwent
CABG between 1971and 1980. The preoperativeand postoperative
smokinghabits of985 patients(95%) couldbe retrievedand were
analyzedin a multivariate Cox analysis. The median follow-upwas 20
years (range 13 to 26 years). Smokingstatus before surgerywas not
associatedwithan increasedrisk of mortality.Patientswho had
smokedbefore surgeryand those who hadnot smokedin the year
before surgeryhad a similarprobabilityof survival. However. smoking
cessationafter surgerywas an independentpredictorof a lower risk of
deathand coronaryreinterventionduringthe 20-year follow-upwhen
comparedwithpatientswho continuedsmoking.Whenadjusted for
..
baseline characteristics, the persistentsmokershada 68% greater risk
of death fromall causes (RR 1.68 [95%confidenceinterval1.33 to
2.13]) and a 75% greater riskof cardiacdeath (RR l.75 [1.30 to 2.37])
as comparedwith patients whohad stopped smokingfor at least one
year after surgery. The estimatedbenefitof survivalfor the quitters
increased from 3% at five years to 14% at IS years.The quitters were
less likely to undergo repeat CABGor a percutaneouscoronary
angioplasty. This study concludedthat patients who continued to
smoke after CABGhad a greater risk of death thanpatients who
stopped smoking. Theyalso underwent repeat revascularization
procedures more frequently. Withthese results, the authors strongly
recommendedcessation of smokingafter CABG.
Otherobservationalstudiesthat were not specific to post CABO
patientsalso suggesta substantialreduction in the rates of subsequent
cardiacevents amongpatients with establishedheart disease who
stopped smokingcomparedwith those who did not :Il l ' ,
rs
1.2.3 Hypertension and IschemicHeart Disease
Blood pressure in thehumanpopulationis normallydistributed,and the
cutoff point for high BP is arbitrary.The diagnosisof'hypertensionin
adults is madewhenthe averageof two or morediastolicBP
measurementson at least two subsequentvisits is 90 mmHg or more
or when the averageof multiplesystolicBP readingson two or more
subsequentvisits is consistentlygreaterthan 140mmHg.
Even thoughthe numberof studies on post CABGpatientswho are
hypertensiveare limited,it is reasonable to extrapolatefrom non
CABGstudiesthat hypertensionis an importantrisk factorsfor
coronaryheart disease.There is overwhelming evidencein the
literaturethathas establishedthat blood pressureelevationis a
commonand powerfulcontnbutor to all of the major cardiovascular
diseases, includingcoronaryartery disease in non CABGpatients. An
earlymeta-analysisthat evaluatedover 5500cardiovascularevents
founda 27 percent increasein risk of coronaryheart disease and a 42
16
percent increase in risk of ischemic stroke for every 7 mm Hg elevation
of diastolic blood pressure2S. Even amongindividualswithoutdiastolic
hypertension, isolated increases in systolic pressureare a risk factor.
Isolated systolic hypertensionmarkedly increases risk for nonfatal
myocardial infarctionand cardiovasculardeath amongboth general
populationsamples 26. Isolated systolichypertension has also been
identified as an independent predictor of coronaryartery disease.
Herlitz J et al. 27 performed a study to describe mortality and morbidity
during a period of 2 years after coronary artery bypass grafting
(CABG) in relation to a history of hypertension. Early mortality and
morbiditywere described during the first 30 days after CABG surgery
while late mortalitywere descnbed between day 30 and 2 years after
CABG surgery. All patients in western Sweden in whom CABG was
undertakenbetween June 1988 and June 1991 were studied . Patients
with simultaneousvalve surgery were excluded in this study . The
authornoted that patients with hypertension (n = 777) differed from
patientswithouthypertension (n = 1348). In the hypertensivegroup,
17
the proportion of women was higher, they were older andmore
frequently bad a historyof congestiveheart failure, diabetesmellitus.
renal dysfunction, cerebrovasculardisease, intermittent claudication
and obesity. They were also more likely to develop post-operative
cerebrovascularcomplicationsand myocardialinfarction. Patients with
hypertensiontended to have increased mortalityduringthe first 30 days
after CABG while the late mortality(between day 30 and 2 years) was
significantlyhigherthan in non-hypertensiveparticipants.Whereasthe
developmentof myocardialinfarctionwas similar in bothgroups, the
hypertensivesubjects developed stroke more frequentlyduring2 years
of follow-up. In a multivariateanalysis includingage, sex.previous
cardiovascular diseases, smoking.ejection fraction,and the occurrence
of three-vesselcoronary artery disease, hypertension was not identified
as an independentpredictor of death either in the early ( < 30 days) or
in the late phase (30 days - 2 years) of follow-up. The study concluded
that patients with a history of hypertensionhave a differentpattern of
risk factors. This group has a higher mean age, includes a higher
proportion of women, and have a higher prevalenceof congestive heart
IS
failure. diabetesmellitus, renal dysfunction, cerebrovasculardisease,
intermittentclaudication, andobesity. Theyalso have an increased
frequency of immediatepost-operativecomplications andan increased
2-year mortality. even ifa history of hypertensionwasnot an
independent predictor of death during the 2 years of follow-up.
1.2.4 Obesity and IschemicHeart Disease
The currentlypreferred definitionsof overweight and obesity are based
on body massindex (BMI) determinations,which approximate total
body fat content and correlatewith disease risk. Overweight is defined
as a BMI of 25 to 29.9 kglm2• Obesity is defined as a BMI greater than
30 kglm' . and morbidobesity by a 8M! greater than40 kglm'.
Obesity is a highlyprevalent conditionamongpatients with coronary
heart disease. In a study of225 participants in an urbancardiac
rehabilitationprogram, 48% were found to be greater than 120% of
ideal body weight. 23 In another review of 659 cardiacrehabilitation
19
participants fromthe more rural University of Vermont program.690/0
were overweightwith a body mass index (BMI ""weight in kg/height in
m1) of greater than25 kglm2• 53% were obese with a 8MI of greater
than 27 kgtm2• and 31% were very obese with a BMI of greater than
30 kgim' .
In the FraminghamHeart Study 29. obesityhas been identifiedas a
significantindependentpredictorof cardiovasculardisease in both men
and women and a desirable target for preventiveinterventions.
However, most studies had only identifiedobesity as a dependant
predictor of cardiovasculardisease. Weightloss is known to be
associated with the loweringof blood pressure levels, measuresof
insulinresistance. lipidlevels, and clottingabnormalities lO; however,
no study has addressed the effects of weight reduction on secondary
coronary events in a CHD population.
20
1.2.5 DiabetesMellitusand IschemicHeart Disease
Diabetes Mellitus is a groupof metabolicdisordersthat results in
hyperglycemia. Thesedisorders have different etiologies. but their
common manifestation. hyperglycemia.is associated with acute and
chronic complicationsincluding cardiovascular diseases. The diagnosis
of diabetes mellitus is made with confirmations of either fastingblood
glucoseof ::= 7.0 mmollL, plasmaglucosevalue of ::= 11.1 mmollL
during a 2 hour Oral GlucoseToleranceTest, or randomplasma
glucoseof ::= 11.1 mmollL along with symptomsof diabetes such as
polyuria,polydipsia,polyphagia,nocturia, weight loss, and blUIIY
vision.
Therehad been extensivestudies includingthe CASS study 31 that
established diabetes mellitus as independentpredictorof
cardiovascular mortality. In the FraminghamStudy, 2o-year follow-up
21
of individualsaged 45 to 74 years at the initial screeningshoweda
twofold to threefoldelevationin the risk of clinicallyevident
atheroscleroticdisease in those with diabetesas comparedwith the
nondiabeticcohort32. These data also showedloss of the protection
against CHD in womenwith diabetes. whohad a rate of CHD
mortalityas highas that in diabeticmen. In the MultipleRisk Factor
Intervention Trial (MRFIT). more than 5000men who reportedtaking
medications for diabetes were monitoredfor an averageof 12 years )).
For every age stratum.ethnicbackground,and risk factor level. men
with diabeteshad an absoluterisk of CHD death more thanthree times
higher thanthat in the nondiabetic cohort,even after adjustmentfor
established risk factors. Similar findingswere seen in a large cohort of
11.554 whitemenand 666 black men between the ages of35 and 64
screenedfrom 1967 to 1973and monitored prospectively for 22 years
Several largestudieshave also emphasizedthe independent adverse
effectof diabeteson mortality after CABG surgery. In the multicenter
22
Bypass AngioplastyRevascularization Investigation (BAR!) study",
patients with diabetes had a highermortalityrate thandid nondiabetic
patients, regardlessof their modeof revascularization (CABO or
PTCA). This findingwasoot unexpected, based 00 the differential of
risk betweenthe diabeticpatientsand all others. But even after the
statistical adjustmentfor the differencesin cardiovascularrisk profile,
(including age, sex, left ventricularfunction,dominance, kidoey
dysfunction.peripheralvasculardisease, historyof congestiveheart
failure and hypertension),diabetic patients showed, during the 5-year
follow-up after enrollment,a significantly higher mortality rate thandid
nondiabeticpatients. These findingsare consistentwith previous
reports about patientswith diabetes who have undergoneCABG
surgery by Morriss JJ et a136• In the Duke data base 37, the 5-year
unadjustedsurvivalrate was 74 percent amongdiabetic patientsand 86
percent amongnondiabeticpatients treated surgically. In another study
that examine diabeticpopulation undergoing coronary
revascularization, insulin dependenceis an added adversepredictorof
5- and IIl-year survival rates )3.
23
1.2.6 Otherrisk factors and IschemicHeart Disease
A decrease in morbidity may be possible with strict diet modification
and lifestylechangesas described by Omish )9 . One hundred fifty of
194 patients who were candidatesfor revascularizationwere able to
avoid surgeryor angioplasty for at least 3 years. The program
consisted of very low-fat, low-cholesteroldiet (vegetarian, 10%fat,
<10 mgldcholesterol, high in complexcarbohydratesand low in simple
sugars), stress managementtechniques, moderateexercise, and
psychosocialsupport. One may argue that these are only broad
encompassingstrategiesthat may well contributeto the lowering of the
manycoronary risk factors that was discussedearlier such as
hyperlipidemia,hypertension,obesity, andperhaps smoking. More
importantly, this studypointed out the importanceof the related
psychosocialissues such as stress management and support networks
in the process of controllingcoronary risk factors.
1.2.7 Multiple Coronary Risk Factors and IschemicHeart Disease
In a recent multivariaterisk factor analysisof clinicaloutcomes 15
year>after coronaryartery bypass graft surgery, Van Brassell et al.
also showed that well-known pre-operative "classical" risk factors if
still present late after surgery, influence the occurrence of clinical
events and treatment of these factors may result in better long-term
prognosis after venous bypass graft surgery40. Four hundred and
twenty-eight consecutive patients who underwent isolated venous
coronary artery bypass surgerywere entered into this study. Fromthe
"classical" risk factors present 5 years after surgery, hypertension is an
incrementalrisk factor for both overall and cardiac mortality, while
smoking for all clinicalevents except mortality. The study also showed
that obesity at the time of surgery is a risk factor for the occurrence of
myocardial infarctionduringfollow-up. This study emphasizes that
much more attention should be paid to treat such factors in order to
expect better long-term results after venousaorta coronary bypass
graftingsurgery.
"
Despite clear evidence that appropriatemanagementofpost-eABG surgical
patients should include comprehensiverisk factor modification,a numberof
studies have shown that these risk factors are not being adequately addressed.
One of these studies looked at the prospectiveinvestigationof 136 female-
patients in Maryland and discovered that no significantchanges in plasma
lipid concentrationwere achieved and 59% of their patients continued to
exhibithypertension6 monthsafter CABG surgery41. An Australianstudy of
103patients suggestedthat cigarette smokingreceived appropriate
interventionand hypertensionreceived some interventionwhile
hyperlipidemiareceived insufficientintervention12 months followingCABG
surgery42. In an earlier study in the Netherlands, in which 226 patients
received instructionswith regard to coronary risk factor modification,there
was a significantreduction in hypertensionprevalence,no significant
modificationof smoking but a significantincrease in the prevalence of
hypercholesterolemia43, These studies, however, have short follow up
periods i.e. 1 year post CABO surgery. In addition.not all importantlyknown
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coronary risk:factors were included in their assessment. These studies
investigated coronaryrisk factors that were limitedto only hyperlipidemia,
hypertension,and smokingstatus.
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1.4 The Research Question
Thestudies mentioned above have shownthat coronaryrisk factors were not
properly addressed and modifiedshortly after CABG surgeryi.e. 6 months to
1 year post-operatively. Therefore. I started conductingthis research study in
1998 with the purpose of investigatingthe long term effect of CABG surgery
i.e. 3 years postoperatively, on a wider selectionof coronaryrisk factors. No
long term data was availableon the effectof coronaryrisk factors in patient
who underwent CABG surgeryat that time when this research was initiated.
Therefore. my research questionwas "00 coronary risk factors change 3
years after CABG surgery?"The major coronaryrisk factors investigated
includehyperlipidemia,hypertension.smokingstatus, and obesity. A
subjectivequestionnairewas also used to assess cardiac rehabilitation
attendance. exercise level. risk factor counselingreceived. andthe degree of
social support availableto subjects post CABG surgery.
1.5 Backgroundto the Study
This is a retrospectivecohort studydesignthat was developedto investigate
whethercoronary risk factorsare modifiedin an extendedperiod of time; i.e.
3 years after CABG surgeryinan urban settingin the AvalonPeninsulaof
Newfoundland. A wider rangeof coronary risk factorswas selectedfor this
investigationcomparedto previouslyavailablestudies. In additionto the
commonlyknown risk factors such as hyperlipidemia,smokingstatus,
hypertension,andBMI, this studyalso investigatesby meansof a post-
CABO surgeryquestionnaire surveyof the following:
a The proportionof subjectswho attendedcardiacrehabilitationprogram
post CABO surgery.
b. The proportionof subjectswho alteredtheir exerciseactivity levelspost
CABO surgery ,
c. The proportionof subjectswho received advice or counselingon cigarette
smokingcessation,weightreduction,and diet modificationpre- and post-
CABO surgery, and
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d. The degree of socialsupportavailableto the subjectswith regardsto risk
factorsmodification
Withthese. we hope to identifyanyimprovements that shouldbe
implementedto enhancethe appropriateuse of our cardiacrehabilitation
serviceand healthcare providers'directedmanagement of coronaryrisk
factors.
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Chapter 2 ~
2.1 Subject Selection
A consecutiveseries of 109subjectswho livedwithin a 200 kilometer radius
of St. John's , Newfoundlandand underwent their first coronary artery bypass
graft (CABO) surgeryin the HealthSciencesCenter, 81.John's between
April I, 1994 and March31, 1995were enteredinto this retrospectivecohort
study . Subjects were obtainedfroma listingof relevantmedicalrecords. The
geographicalareas of samplesubjects' residences in the AvalonPeninsulaof
Newfoundland includedthe areas extendingto Arnold's Cove in the west,
Bay de Verde in the north, Placentiain the southwestand Trepassyin the
south . This population was conveniently selected to allow the samples
subjects to attendthe hospital for the necessaryinterview and blood sampling
in this study. An illustrat ed map of geographical areas covered in this study is
shown inFigure I.
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2.1.1 Figure l. Geographic Areas of Study Population
!"., Geograp h ic a reas
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2.2 Data Collection
2.2.1 TheInclusionand ExclusionCriteria
Inclusion Criteria·
1. All persons who underwenta first CABGsurgery at the Health
ScienceCenter duringthe studyperiod, between April I , 1994 and
March 31, 1995.
Exclusion Criteria·
1. Personswho underwent coronary artery bypass surgery with
concomitant valvularsurgery whenthe latter was the primary
surgical procedure.
2. Personswho underwentrepeat coronary arterybypass surgery.
ra
3. Persons who were diagnosedwith a major or life threatening
illnesses(i.e., malignancy)not relatedto coronaryarterydisease
wilhin 6 monthspost CABG surgery.
4. Persons who residedoutside the geographicalareas of study
5. Persons who eitherdid not consent to the study,lost to follow-up,
or died immediately following CABGsurgery
2.2.2 RetrospectiyeChart Review
2.2.2.1 Subject Identification
The initialprocess involvedthe abstractionof data fromthe
operatingrooms' log books for subjectsscheduledfor CABO
surgeryduringthe studyperiod. Potentialsubjects to be enrolled
in this studywere first identifiedby reviewingthese contact
schedulelists. Namesof subjects,names of their attendingand
family physicians, healthinsurancenumber, date of surgery,
previousCABGsurgery,concomitantsurgicalprocedures, and
historyof seriouslife threateningillnesseswere reviewed.
Demographic data collectedinclude sex, date of birth. contact
telephonenumbers, and address (Appendixla). Subject records
were coded for the purposeof maintainingconfidentiality. No
names were used on the chart abstract forms. Access to
subjects' namesand code nwnberswas electronicallylimited by
passwordsto the principalinvestigatorof the study. All records
of subjectswere kept in a lockedroom in the Cardiology
Research Centre at the Health Science Centre.
In each case, subjects' medical records were obtained from the
Departmentof Medical Records usingsubjects' health insurance
numbers. I reviewed informationconcerning currentand past
medicaland surgical history, diagnostic investigations,
therapeutic interventions, and clinical outcomes for eligibility of
entry usingthe criteria specified in this study.
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2.2.2.2 Reviewsof MedicalRecords
Retrospectivechart reviews were then carriedout for all subjects
enrolled in thisstudyusingthe guidein Appendix lb. Thedata
collected includehospital records of medicaland social history
(demographics, medical history, coronary risk factors
identification), and physicalexamination (bloodpressure
measurement, weight, height) as well as prior laboratory
investigations(senun fastinglipid profile). The portions of the
medical recordthat were reviewedincluded those portions
generated, directlyor indirectly, by the physiciansresponsible
for the care of the patients. And thus, informationmay be
abstracted fromthe emergency record. outpatientnotes, referral
letters. admissionhistory and physical examination,progress
notes, problemlists. consultationreports,operativereports,
physicianorder sheets. medicationprofile, test reports , discharge
summaries and pertinent correspondence.
J6
Positivecigarettesmokinghistoryis defined as any cigarette
smokedin the 5 years periodpriorto CABGsurgery.The
numberof cigarettesmokedper dayis determined by the largest
numberof cigarettesmokedperday at anyone timeduringthis 5
years period. Bloodpressurereadingswere takenfromthe most
recentpre-CABGmeasurements. Theseare primarilyfromthe
vitalsignspagesof subjects' in-hospitalcharts. If bloodpressure
measurements were not availablein these pages, thenreadings
were takenfromthe pre-operative anesthetists' records. I was
unableto determineif these measurements were performedin
the sitting.standing,or supinepositions. Weightand height
measurementswere takenfrompre-operativeanesthetists'
records.Most recent fastinglipidprofileswere takenfrom
subjects' familyphysiciansrecordswithin the 5 yearsperiod
prior to CABGsurgery.I wasunableto determinethe numberof
hours"fasted" priorto venepuncture for the fastinglipidprofiles.
Randomlipidprofileswere not accepted.Subjects' medication
profilewas obtainedfromthe most recent list of medications
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fromthe subjects' in-hospitalchartsor the anesthetists' records
prior to CABO surgery. A positive history of counseling for
weightreductionand diet modification were determinedby any
record of dietician/nursing referralor physiciandocwnentation
of such sessions in subjects' chan. The sameapplies for a
positive historyof counselingfor smoking. Any previous use of
nicotinereplacement(patch,gum, inhaler.nasal spray)or
bupropion for the purposeof smoking cessation were considered
positivehistory for smokingcessationcounseling. Any records
of wordings in subjects' files such as "advised, discussed,
counseled, talked,warned,recommended, reduce, or stop" were
accepted as a positive counselinghistory respectively in the 5
years period prior to CABO surgery. Exercise levels of subjects
prior to CABG surgerywere not available. Thischart review
system allowsviewingof the docwnentationof counseling
eventsthat have taken place. However,it is recognizedthat
these counseling events may have been performed but not
documented.
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2.2.3 Subject Survey
2.2.3.1 SubjectRecruitment
The principalinvestigatormet with the tertiary-careattending
physiciansin direct care of the subjects to explain the research
project. Invitationletters addressed to the subjects were givento
the attending physiciansonce theyhave agreedto introduce the
me and the research study to their patients. These invitation
letters were approved by the attendingphysicians.
Consent forms, accompaniedby the invitationletters to attend
the hospital for history-taking. physical examination,and
collectionof blood were mailed to the last known address of
these subjects. Subjects were asked to reply eitherby mail
email,faxor reverse-charged telephonecall.A self-addressed
stamped envelope was enclosed to facilitate reply. Subjects who
did not respond within 14 days were contacted by telephone
calls fromthe principalinvestigatorof this study. Appointments
were alsomade by the principleinvestigatorfor the subjectswho
consentedto participatein this study to attendthe hospital.
Subjectswho did not wish to participatein the studywere
excluded.
2.2.3.2 SubjectInterview
All subjectswho agreed to participatein this study attendedthe
interviewat the HealthScienceCentreand were seen by the me.
I then took a historyof cardiac andnon-cardiaceventspost
CABOsurgery,cigarettesmoking,diet modification, weight
reduction,exercise,and present medicationusing a standardized
questionnaire(Appendix 11). Pre-operativerisk factors were not
asked at the interviewin order to reducerecall bias even though
this data may providemore completepre-operativedata.
Reducingthis recall bias would lead to increased validityof
overallconclusions. However, this strategy may have resulted in
reduced samplesize for comparisonagainst post CABG data
and thus reducedpower of my conclusions. Medications
classified as antihypertensive included all ACE inhibitors, A2R
antagonists, diuretics, all vasodilators (nitrates. hydralazine.
calciumchannelblockers), and all sympathoplegics(beta-
blockers. clonidme. reserpine). I wasunableto exclude the use
of these antihypertensives as antianginals.Medicationsclassified
as antilipidmedications included all HMG-CoAreductase
inhibitors, fibrates, resin, niacin, and probucol. Initially,a more
detailed history was taken with the questionnaire thanwhatwas
needed for this study. Only relevant infonnation was abstracted
far the purposeof this study. Subjects' heights, weights, and
sitting blood pressures were also taken in a standardized fashion.
Overnight tasting serwn lipid profile levels also performed. All
blood tests were analyzed at the laboratory of the center.
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2.2.3.3 StandardizedAssessment and Measwements
Height aDd Weigh t: Subjects' heights and weightswere
measuredby a stadiometer and a clinicalbalance scale in light
clothingwith shoes removed.BodyMass Index (BM!) was
calculatedas weight in kilograms dividedby height in meters
squared.
Blood Pressure: Subjects' blood pressures were measured to
the nearest I mmHg in the sitting position in the right arm after
sittingstill for 10 minutesusing a mercury sphygmomanometer.
AUblood pressure measurementswere repeated at least twice.
The average systolicand diastolic blood.pressures were adopted
for thepurposeof this study.
Blood Sampling: Blood for fasting serum total cholesterol. HDL
cholesterol,LDLcholesterol. and triglycerides was drawn
throughvenepuncturein the right antecubital fossa aftera
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minimum of 12-hourfast. Standardenzymaticmethods were
used to measureserum cholesterol(cholesterol oxidase) and
triglyceride, (lipase-glycerol kinase (GKlGPO). HDL
cholesterol wasmeasuredafterprecipitation of apolipoproterin
B-containinglipoproteinswith heparin and manganese.or with
phosphotungstateand magnesium.and assayed by the
cholesterol oxidasemethod.Valuesobtainedusingthe
photophotungstateand magnesiummethod were adjusted to be
equivalentto those with the heparin and manganesemethod
using the regressionequation;phosphotungstateand magnesium
method= 0.09x heparinand manganesemethod- 0.Q7. LDL
cholesterol wascalculated fromthe Friedewald equation44.
Smoking Staw: Currentsmoking status wasassessed by the
standard questionnaire(Appendix Il). At baseline. smokingwas
definedas any use of cigarettes during the 6 months before
admission. At 3 yearspost CABG surgery, smokingwas defined
"
as any use of cigarettesat the time of follow-up.Average
numberof cigarettes smokedperday was also questioned.
ExerciseLevel: Physicalactivitywas measured by asking
subjects to completethe 7-DAY ACI1VITY RECALL45
(Appendix Ill), a measure of total energyexpenditure,at 3 years
post coronaryartery bypass graft surgery.The 7-DAY
ACTIVITYRECALLis a self-reportedmeasure of physical
activity, includingwork and leisureactivities, that asks
individualsto quantifythe time spent in light,moderate and
vigorousactivitieson an average weekday and weekendday. An
estimate of total kilocalories of energy per kilogramofbody
weight perday is then calculated. Originaltest-retest reliability
of the compooents afthe 7-DAY ACTIVITY RECALL ranged
from0.65 to 0.83 J'.
2.3 Outcome Measuresand Data Analysis
The primaryoutcomemeasure was the presence of a significantmodification
in lipid profiles 3 years after CABG surgery. The secondaryoutcome
measures includedsignificantmodificationof arterial blood pressures, BMI,
and cigarette smoking.
Descriptive statisticswere used to describe distributionof subjects eligible
for the study, levelof counselingpre and post CABG surgery. exercise habits,
and cardiac rehabilitationprogramattendance. The significanceof any mean
change in continuousvariable risk factors from pre-operationto 3 years
follow-upwas determinedby paired sample I tests; for dichotomous variables
such as smokingstatus. the significancewas determinedby the Chi-square
tests. Comparisons of baseline demographiccharacteristics and risk factor
status were performedwith tests of analysisof variance.
"
2.4 Sample Population
Samplepopulationfor this studyis definedas all personswho livedin the
AvalonPeninsulaof Newfoundlandand hadunderwentCABG surgeryat the
HealthScience Centre , 51.John's between April 1, 1994 and March31,
1995.
I had initially hoped for 100%ascertainmentbased on this geographical
location.However. I couldonly obtained 57% ascertainmentto this study
duringthe enrollmentprocess. Calculationsperformedindicated that this
samplesize wasinadequatefor multivariate analysisbut sufficient to allow
me to assess BMI, bloodpressure and a part of lipidprofile. i.e. total
cholesterollevels. An exampleof suchcalculationsis as followed.
In the middleage group, for each I% increase in total cholesterol. coronary
heart diseaserisk increases by an estimated3%.46 It was determinedthat a
10%increase (~) in total cholesterolwhich is associated with 30% increase
in cardiovascularrisk would be clinically significant.Standarddeviation (5)
for fasting total cholesterol in subjects with ischemicheart disease is
approximately0.9. In order to achievea statistically significanceof a =0.05
and a power (1. 13) of 80% mathematically. a sample size of~ 28 subjects is
needed.
Limitationof this study resultingfromthe smallsample size will be further
discussed in this thesis.
Chapter 3. ~
Of a total of 109 subjects who had had CABG surgeryperformedwithinthe
specifiedgeographicalregion and study period, 92 subjects were eligible to
be entered into this study . AUoftbese subjects underwentCABG surgery at
the Health Science Centre where retrospective chart reviews were performed.
The excluded subjects comprised7 subjects who hadconcomitantvalvular
surgery, 7 subjects who had repeat CABG surgery, and 3 subjects who were
diagnosedwith metastatic breast cancer, breast cancer. and bladder cancer,
respectively, shortly(within 6 months)after theirCABGprocedures.
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Among 92 subjects wbo qualified to be included in this study, 52 (56.5 %)
subjects agreedand19(20.7%)refused to participateinthe3 yearspost-
CABGfe llow up interview. Fourteen (15.2%)subjectsdiedduring the follow
up periodafter CABG surgery includiog 3 subjects who died intraoperatively.
Six(6.5%) subjects couldnotbe contacted bymail.phone.orthrough their
family physician andwere,therefore, deemedlost to follow-up.Therewas 1
(1.1%) subjectwhodropped outhalfway through theinterview process.See
Figure 2.
Figure 2. Distribution of Subjects Eligible for the Study
0 =92
3.1 BaselineComparisons
Comparisons of baseline characteristics betweensubjectswhoconsented to
participate in the study(study group) and those who either refused to
participate. dropped out, or werenotcontactable (nonparticipantgroup) were
performed forsex, age. lipid profile, arterial bloodpressures. BMI.and
cigarette smokingstatus.
Of the total of 52 subjects who conseuted to the study (study group), fasting
totalcholesterol levels were performed in57.7% (n "" 30) of subjects prior to
theirCABGsurgeries. Complete fasting lipidprofiles weremeasured in
44.2% (0 ~ 23) of studiedsubjects prior to CABG surgery.
Of those whorefusedto participate, dropped out.orwerenotcontactable for
thestudy (non-participantgroup. n = 26), 20 subjectshadhadserum. total
cholesterol levelsmeasured and16 subjects hadhadthe breakdowns of serum
lipidprofile perfonned.
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The study groupdifferedfromthe non-participantgroupin that there were
fewer females (21.2%)as opposed to the 26.9%femalesin the non-
participant group . The meanage for the study groupwas slightlyolder
compared to the non-participant group(63.6 yearsold vs. 61.0 years old).
Mean total cholesterollevelsin the studygroupandnon-participantgroup
were 5.5 mmol/land 5.6 mmol/lrespectively. Meansystolicblood pressure
and diastolic bloodpressurewere similarin both groups(126.9 mmHg/78.3
mrnHgvs. 126.2mrnHgl72.2 mrnHgrespectively).Mean 8M! was 29.2
KglM2in the studygroupwhereas meanBMI in the non-participantgroup
was 28.0 KglM2. There were 12and 6 cigarettesmokersin the study group
and non-participantgrouprespectively,both representing23% of each group
(12 out of 52 in studygroupand 6 out of26 in non-participantgroup).
I did not showany statistically significantdifferencesin the baseline
characteristicsof subjectswho consentedto the studyand thosewho either
refused to participate,droppedout, or were not contaetablefor the study.
However. the numbersstudiedare small
so
Comparison of characteristicsbetweensubjects whoconsentedto participate
in the study (study group) and thosewho died during the post-eABG period
(deceased group) were alsoperfonued.
The study group (0 ~ 52) differsfromthe deceased group(0 ~ 14) in that
there werefewerfemales (21.2%)inthestudygroupwhencompared to the
deceasedgroup (28.6%). Themeanage in thestudy group wasyounger (63.6
yearsold) as opposed to thedeceasedgroup (68.7 yearsold).Meansystolic
anddiastolicbloodpressures wereslightlyhigherinthe deceasedgroup
(140.0 mmHgand M.OmmHg)whencompared10 the study group(126.9
mmHgand 7S.3 mmHg). MeanBMI were similar in bothgroups (29.2 KgIM'
vs. 27.3 KgfM2) . Thepercentage of cigarette smokersin thedeceased group
is higher(29%)compared to thestudygroup (23%). I didnothavethepower
to showanystatistical significance in thealldifferences stated abovebetween
the studygroupand the deceased group.
Thirteenout of 14 subjectswho deceasedduringthe post-CABGperioddid
nothave lipidprofile performed priorto theirCABG surgery. Sevenof these
14 subjects had bad coronaryeventsduring the 3 years post-eABG periods.
"
Thesecoronaryeventsincludemyocardial infarction. congestiveheart failure.
and angina.The other7 who did notexperiencepost.oCABG coronaryevents
include3 subjectswho died intraoperatively as a resultof complications
duringCABGsurgery, I who died of cerebralbleed,1 who died of liver
cancer. I who died of coloncancerand I who died of sepsisduringthe
followup periodpost CABGsurgery.
"
3.2 Comparisons in the Study GroUPbefore and 3 years after CABQ
The mean followup timeperiodfor the studied subjectswas 3.2 years
(n::52). Changes in major study outcomes, presented in Table I and Table 2
are as follows:
Table 1
CQmparisonsof'MEANS in the StudyGroupbeforeand 3)Ul'1 afterCABOSurgery
BdoreCABGIUtJerY 3 Yean After CABO SW'geI}' P.....
TocalCboleslerolLevels Mom " 5.65:1:0.90 Mom = 4.92 :1: 0.84 p < O.OOI
mmolII 0 - 30 D.-3O
Tri8Iyceride Le\~ls Mom - 1.03 * 1.22 M~ - 1.89 * 1.08 p - 0.291
mmolII 0 - 23 0 - 23 NS
HDLLevcls Mom '" 1.15:1:0.53 M~ "' 1.24:1:0.34 p - O.410
mmolII 0 - 13 0.- 13 "" S
W L,=" Mom - 3.31 % 1.08 Mom "'2 .69.:1: 0.80 p -Q.OIO
mmolII , -23 , -23
S,"IlDIicBP Mom -116.9%1 6.1 Mom - I3S.0 :t.I7.J p -0.OO3
mmH 0 -52 0 -S2
DiastoI.ic BP Mom - 71.3 :*:9.0 Mom - SH .:I:9.7 p < O.OOI
_H. 0 ""52 a- 52
BMI Mom - 29.0 :t.S.7 Mom ~ 30. I:*: S.4 p - O.OOI
.....' a -52 0 -52
Numberofsmokers , - 12
" -.
Numberofciga:ettes
smokedperdayamong Mom - 13.3 :t.4.4 M~, "12.5 :t.4.6
"""""
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Table2 :
C........nVWd; of PROPORTIONS in StudvC'm'II' beforeand3 \IC:lIISafterCABO SUTVO!
BdceeCAllG J Yc:aBAfta' P\'lI1ue
""I"Y CAllG""I"Y
Total Cholesterol Levcls , - 30 0 - 30
< 5.2 mr001l1 36.7% 63.3% p "O.O I
>.UmmoUl 63.3% 36.7%
rrr 1.=1, 0 -23 11-23
<2.Jmmolll 65.2% 78.3% p-O.456(NS)
> 2.3 mmo!I1 JU% 21.7%
HDL..- 0 -23 0 -23
> 1.Ommolll. 52_2% 21.7% P " 0.0.51 (NS )
<1. Ommolll. 47.8% 78.3%
WL!..eYd s 11-23 , -23
~ 2.6rnmo111 11.4% 60.9% p - O.021
> 2.6mmol11 82.6% 39.1%
On Anl ilillid McdK:atioa 11-30 a -3D
Yes "7% 63.3% p - O.IS7 (NS)
N, 43.3% 36.7%
S stolicBP a - 52 a -52
2=140mmH 30.8% 46.2% p - O.049
<l40mmH 69.2% 53,8%
DiaslolicBP 11-'2 a -52
>'" 19.2% 53.8% p<O.OOI
< 90mmH SO.'" ...'"
""""""'"
11-'2 a- 52
""-
7.7% 11.5% p -O.2.50(NS)
Onl to2 Antihypertcosive 76.9% 75.0%
Mol
OnJto4Anti!lyperterls 15.4'" n .N
Mod
8M! 0 - S2 0 -52
<2 5 K 26.9% 13.'''0 p - O.OO8
>2 5 K 73.1% 86.'"
S"""" a -52 a - 52y~ 23.1"- 1504% P " 0.086 (NS)
No 16.9% 84.6%
3.3 Result Analysis· Major Coronary RiskFactors
3.3.1 Hyperlipidemia
Of the total sample of 52 subjects studied, fasting total cholesterol
levels were performedin 57.7% (n =30) of subjects priorto their
CABG surgeries. Complete fastinglipid profileswere measured in
44.2% (n = 23) of studiedsubjects prior to CABG surgery.
The proportionof subjects with high fasting serumtotal cholesterol (>
5.2 mmolll) decreased significantly (p ~ 0.01, n - 30) from 63.3%
before CABG surgeryto 36.7% at 3 years post CABG surgery. The
mean decrease in fasting serumtotal cbolesterollevels was 0 .73
mmolA.
The proportion of subjects with fasting serum triglycerides levels > 2.3
mmol/ldecreased from 34.8% before their CABG surgery to 21.7% at
3 years post CABG surgery. However. this decrease was not
"
statistically significant (p ~ 0.456, D ~ 23). The detected mean decrease
in trigtycerides levelswas0.19 nnno1J1.
An oppositepatternwasnoted. in the proportionof subjectswith high
fasting serumHOLlevels. The percentage of subjects with serwn HOL
levels z 1.0 mmoVldecreased from52.2% before their CABG
surgeriesto 21.7% 3 years aftertheirCABG surgeries. This decrease
was, however, not statisticallysignificant (p = 0.051, n = 23). Mean
serum HOL levels increased marginally1.15 mmoVlpreoperativelyto
1.24 mmoll1 at 3 years post CABOsurgery.
Similarto the proportionof serumtotal cholesterol levels,the
proportionof subjectswith serumWL > 2.6 mmol/ldecreased
significantly from82.6% beforeCABG surgeryto 39.1% at 3 years
after the surgery (p = 0.021, n= 23). The mean decrease detected was
0.62 mmolllin this groupof subjects.
"
The improvement in cbolesterollevels can be partlyexplainedby the
increasedpercentageof subjectswhowere treatedwith antilipid
medications3 yearspost-CABGsurgery (63.3%) as opposedto the
percentagepriorto their surgery(56.7%) andthe potentiallyincrease in
the dosagesof thesemedications. Data on dosagesof antilipid
medicationswerenotcollected.Other factorssuchas diet modification
and increasedexerciseactivitypost-CABGsurgerycould also have
had effectson this improvement in lipidprofile.
Table3
Comparison of subjects ' demographic &lid post CABO lipid prollk ben\-cmlbe IOla1 enro lled sub;ects
(n- 52), subjectswhohad~ CABO lipid profile (n-23), and subjects wbodid DOt ha,-cpre CABO lipid
profiledperformed (n"'29)
Total EnmIIcd Subp:ts Subjccts ",bo had Subjcctswho did DOt ha...c
PrcCABGlipjdprofi1e PrcCABG lipid profik
~" ~21 ~29Sa Mol< "' 78.8% Mol< "' 82.6% Mol< - 72.. %
fcmak -21.2% Female - H .•" FcmaIe "'2 7.6%
""
Moon - 6l. 6 :i:10.l
""'"
- 62.1 :i: II .•
""'"
" 64.7 :i:9.5
TotaICboIestcroI~ Moon "' 5.1I :i:I.04
""'"
- •. 78:i: 0.8l
""'"
" 5.55 :i:1.OS
mmoIII
TriglyceridcLc:ve1s M= "' 1.78 :i:0.91 M= - 1.89 :i:I.OS
""'"
"1 .69 :i:0.76
_Ill
HDLLevcls M= - 1.16 :i:0.l l
""'"
- 1.24 :i:O.34
""'"
- 1.09 * 0.28
mmoIII
LDLl..tNels
""'"
- 3.22 :i:1.03 M= - 2.69 :i:0.80
""'"
- 3.6l * 1.0 1
mmoIII
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All subjects enrolled in this study (0 ~ 52) bad post CABG lipid profile
performed. Table3 showedcomparisons of subjects' demographics
and post CABG lipid profileamongthe total enrolled subjects (0 = 52).
subjects whohadlipid profileinvestigatedpriorto theirCABGsurgery
(0 ~ 23). and subjects who did oot have their lipid profiled investigated
priorto theirCABGsurgery (n = 29). Subjects whodidnothaveserum
lipidprofiledetenninationswereslightlyolderandhadhigher
proportion of womencompared to thesubjects whohadpreCABG
lipidprofiledeterminations. Three-year postCABGlipidprofilesin
subjects who did DOt bave pre CABG lipidprofile performedappeared
less well controlled compared to subjects whohadpreCABGlipid
profileperformed.Theformer group hadhigher mean serum total
cholesterol (5.55 ± 1.08 mmolllvs. 4.78 ± 0.83 mmolll).lowerHDL
levels (1.09 ± 0.28 mmolllvs, 1.24 ± 0.34 mmolll). and higher LDL
levels (3.63 ± 1.01 mmolllvs.2.69 ± 0.80 mmolll) companedto the
latter. Serumtriglycerideslevels wererelativelyunchanged(1.69 ±
0.76 mmol/l VS. 1.89 ± 1.08 mmol/l)betweenthe2 groups.
"
3.3.2~
All 52 subjectsstudiedhad had theirarterialbloodpressuremeasured
prior to CABG surgery. Theproportionof subjectswith systolicblood
pressuresof :::140 mmHgincreased significantly from30 .8% before
CABG surgeryto 46.2% at 3 yearsafterCABG surgery(p =0.049, n
= 52). The meansystolicbloodpressureincreased from 126.9± 16.1
before CABG surgery 10 135.0 ± 17.3 at3 years after CABG surgery.
This was alsoseen in the proportionof diastolicblood pressure2:90
mmHgwhich increased significantly from 19.2% pre-CABGto 53.8%
post CABO surgery (p < 0.001 , n = 52). The mean increasein diastolic
blood pressure was 7.1 mmHg. The mean systolic and diastolic blood
pressures were 135.0mmHg and 85.3 mmHg respectively at3 years
postCABG.
Reasonsfor the better controlof bloodpressurepre-CABGsurgery
will be discussedfurtherin this thesis.
"
3.3.3 BodyMassIndex
Heightin meter (m) andweightin kilogram(kg) wereavailable forall
52 subjects prior to CABG surgery. Body mass index (BMl) was
calculated usingtheseparameters.The proportion of subjects with
body massindex(BMI)> 25 Kg/M2 increased significantly from
73.1%before CABGsurgeryto 86.5%at 3 yearspost CABG surgery
(p = 0.008, n = 52). The detectedmeanincreasewas 1.1KglMl .
Subjects with BMI > 25 Kg/M' consisted of 86.5% (0 ~ 45) of the
Study Group3 year>post-CABG surgery. Amoogthese. 57.8% (0 -
26) reportedin thequestionnaire thattheyhavereceivedadvice or
counseling withregards to weightreduction by healthcare providers,
mends, or family members. Theother42.2%(n = 19)denied receiving
thisadviceor counseling. Comparing to the 73.1%(n = 38) of pre-
CABG subjects with BMI > 25 Kg/M'. 42.1% (0 = 16) were found to
have documented weightreduction counselingin theirchartspriorto
theirsurgery. Amongtheoverweight3 yearspost-CABG surgery
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subjects, 62.2% (0 = 28) reported they received advice no diet
modificationfrombea1thcare providers.friends,or family members.
The samenumberof subjectsalsoreponed that they modifiedtheir
eating habitsince theirCABGsurgery. Chartreviewof the pre-CABG
period revealed that only 39.5% (0 = 15) of overweightsubjects had
documented diet modifyingcounselingsessionseither by the
physicians, nurses, or the dietitians. See Figure3.
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Figure 3. Counseling Among Overweight Subjects (BM I > 25
Kg/M')
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Desp ite an increase in the proportion of overweight subjects receiving
weight reduction and diet modification counseling post-CABG surgery.
the BMI among the overweight group had increased significantly
comp aring to their 8MI pre-CABO surgery . This was an interesting
finding and win be furthe r explored in the discussion section.
.,
The results of the self reported levelof exerciseQuestionnaire showed
that amongthe overweightsubjects, 22.2% (0 = IO)reported that they
were exercisingless comparedto their activitiesprior to CABG
surgery, 26.7% (0 = 12) reported no change in their activities before
and after surgery, while 51.1%(0 = 23) reported that theywere
exercising more after theirCABG surgery. When compared to the noo-
overweight subjects (n =7), all oftbem reported that they were
exercising moreafter their CABG surgery. It seems that exercise levels
among the overweightsubjects in this study differsfromthe 000-
overweight subjects in that approximatelybalf(48.90Io}of the
overweight subjects were doing less activitiesor at the same level of
activities post CABG surgery.These exercise level results obtained
from Questionnaire will be further addressed later.
Fastinglipid profileswere performedon all 52 subjects enrolled in this
study3 years post CABG surgery. Mean total cholesterol amongthe
overweightsubjects was higher (5.31 ± 1.05 mmolll)compared to the
non-overweight subjects (4.55 ± 0.73 mmolll). Mean LDL levels
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among overweightsubjects was also higher (3.32 ± 1.01 mmolll)
compared to the non-overweightsubjects (2.S2 ± 0.91 mmol/l). These
were not surprisingfindings as overweight individualswere more likely
to have increasedserum lipid determinationsin general. Mean
triglycerides and HOLlevels appeared to be similarbetween
overweight subjects (1.77 ± 0.87mmollland 1.15 ± 0.29 mmolll
respectively)and non-overweight subjects (1.83 ± 1.21 nunoVland
1.20 ± 0.44 mmol/lrespectively).
The results of this study appeared to indicatethat even though fasting
total cholesterol and WL levels were significantlyimproved3 years
post CABG surgery. there were also higher proportionof overweight
subjects afterthe surgery.One major drawback of such comparisons in
this study is that while BMI were available for aU52 subjects in this
study. comparisonsof total cholesterol levels and WL were only
availablefor the 30 and 23 subjects who had had the lipid
determinationsdone prior to CABO surgery,
..
3.3.4. Cigarette Smoking
The smokingstatus of all 52 subjects studiedwas available in
retrospective chart review. However, the numberof smokers (n = 12)
was too small to produce statistically meaningfulresults based on
sample size calculation. The proportionof cigarette smokingdecreased
slightly from 23.1% before CABG surgery to 15.4% at 3 years after
CABG surgery. However, this changedid not appear to be statistically
significant(p = 0.086, n ~ 52). This translates to only 4 out of the 12
smokers who had stopped smoking following their CABG surgery. The
mean decrease in the number of cigarette smoked per day was
approximately 1 cigarette per day among smokers 3 years post CABG
surgery. This findingwas not unexpected given the fact that cigarette
smoking has long knownto be a difficult behavior to modify. There
were no new smokers 3 years after CABG surgery.
There were 15.4% subjects (n = 8) who were cigarette smokers 3 years
after their CABG surgeries. Of these 8 subjects, 87.5% of subjects (0 =
es
7) admitted that they had receivedadvice or counselingwith regards to
smoking cessation either fromhealthcareproviders. friends. or family
members. 12.5% of subjects (n = 1) denied receivingany formof
adviceor counseling with regardsto smokingcessation.
There were 23.1% subjects (n = 12) who were cigarette smokers prior
to their CABG surgeries.Of these 12 subjects, smoking cessation
counseling was documented in 75% of subjects (n =9). See Figure 4.
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Figure 4. Smoking Cessa tion Counseling Among Smokers
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Similar to weight reduction and diet modification counseling. chart
review ofdocumen ted smoking cessation counseli ng may be an
underestimation of the actua l amount of advice subject received prior
to their surgery. Figure 4 showed that the increase in the proportion of
subje cts receiving smoking cessation counseling post-CABG was very
small. Perhaps this was one of many contributory reasons why the
proportio n of cigarette smokers had only decreased slightly from pre-
CABG to post-CABG surgery .
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3.3.5 Exercise Levels
Thirty subjects (57.7%) reported thatthey were physicallyexercising
more at 3 years post CABGsurgery comparedto the period prior to
their CABG surgery. Approximately 19.2% of subjects (n = 10)
reported that they were exercising less compared to their activities
prior to CABG surgerywhile 23.1%of subjects (n = 12)reported no
change in their exercise activities beforeand after CABGsurgery. See
Figure5. Informationon factors that may have affectedexercise levels
such as angina,claudication, and musculoskeletal limitation were not
collected.
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Figure 5. Post-CABG Exercise Activities Level Compared to Pre-
CABG Surgery
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3.4 Result Analysis: Other Results
3.4.1. Cardiac Rehabilitation Program Attendanc e
Results from the questionnaire obtained in this study revealed that only
19.2% (n ~ 10) ofthe subjects bad undertaken the cardiac
rehabilitation program while 80.8% (n = 42) did not. See Figure6. Post
CABG lipid profile among subjects who had undertaken the cardiac
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rehabilitation program bad lowermeanserum total cholesterol (4.79 ±
0.59 mmoVl vs. 5.31 ± 1.11 mmol/l). andlower meanLOt levels (2.85
± 0.78 mmo/1 vs. 3.30 ± mmoVl) compared to thesubjects whodidnot
attend the program . Mean serum triglyceridesand IIDL levels were
relatively unchanged(1.73 ± 0.95 mmoVlvs. 1.79 ± 0.91 mmoVland
1.09 ± 0.30 mmoVl vs. 1.17 ± 0.32 mmoVl respectively) between these
2 groups. Subjectswhoattended thecardiac rehabilitation program
alsohadlowersystolicanddiastolic bloodpressure at 3 yearspost
CABGsurgery compared to thesubjects who didnotattendthe
program (126.8 ± 23.8 mmlf g vs. 136.8 ± 15.0 mmHg and 80.0 ± 13.1
mmHg vs. 86.5 ± 8.5 mmHg respectively). 8M! at 3 yean; post CABG
was alsoloweramong subjectswhoattendedtheprogram (28.86 ± SA
KglM2) compared to the subjects whodidnot attend the program
(30.37 ± 5.4 KgIM').
Figure 6. Post-CABG Cardiac Rehabilitation Program Anendance
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3.4.2 Social SUPPOrt
No
Of a total of 52 subjects studied, 84 .6% of subjects (n ~ 44) reported
thattheyhadone or more family members, friends. orhealthcare
workers whogave themsupport in modifyingtheircoronary risk
factors during the 3 years post-CABG surgery period . No pre-CABG
surgerydatawereextracted for this information,
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Chapter 4. Discussion
4.1 Changes in CoronaryRisk Factors
The aim of this studywas to investigatewhether coronary risk factors are
modified in the long term; i.e. 3 years followingCABO surgery in a selected
group of subjects.
4.1.1 Hvoerlipidemia
The most noteworthyfinding in this study was the significant
improvement in the lipid profileof subjects 3 years after CABO
surgery. This result is consistent with a similarprospective cohort
study designedby Skinner JS 47 which also observed a significant
decrease in total cholesterol levels after examining353 patients
following their first time CABO surgery. It is well known that the
progression of the atherosclerotic process can be slowed down both in
the coronaryarteries and the venous grafts by phannacological lipid
modification after bypass surgery 48. Various potent lipid-lowering
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agents are now available.Patients and healthcareprovidershave
become moreaware oftbe potentialbenefitsofbetter lipid control in
secondaryprevention of coronary heart diseasewith both
pharmacologicalandnon-pharmacological methods. It hasalsobeen
recommended to start patients on lipid-loweringagents immediately
during the post operativecourse of stay in the hospital. These factors
could possibly explain the significantdecrease in fasting serum total
cholesterol, and LDL levels in subjects post CABG surgery. Similarly,
serum triglycerideslevels bad also decreased post CABO surgery
althoughthe decrease was not statisticallysignificant.
4. 1.2 ~
A significantworseningof blood pressure control was found in this
study. This pattern of worsening blood pressure is supported by a short
term cohort studyby Allen et al. 31 that examined 157 female patients 6
months followingisolated first time CABG surgery. However, an open
randomizedcontrolled trial by Engblom E et al. 49 did not find any
13
significantchangesbetween preoperativeblood pressure and
postoperative bloodpressure. Engblom's study examined228 post-
CABG patientswho were allocated into a rehabilitationgroup (n =
119) and a bospital (control)group (0 - 109). Therehabilitationgroup
received a 3-phase muftifactorial institution-basedrehabilitation
program on modificationof CAD risk factors. This programconsisted
of preoperativeinformation session, postoperativegroup discussion,5-
hour nutritionistadvice, 2l -hour supervisedexercise trainingover the
period of 3 weeks, and finally a refresher course 8 months
postoperatively. One woufdexpect that a programsuch as that would
lead to better controlof blood pressure. However, there were no
significantchanges between preoperative blood pressure and I-year
postoperativeblood pressure in either groupin that study.
Eagblom's study differs from my study in that I examinedcoronary risk
factors modificationover an extended 3 years post CABG surgery as
opposed to Engblom's l -year post CABG study. In my study, I believe
that there was a heightenedcontrol of blood pressure amongthe
subjects while in hospital pre-operatively in order to minimizeangina
symptoms. Therefore, they were more likely to have optimizedcontrol
of blood pressure as an initial non-surgicalmanagement approach prior
to the enlistment forCABG surgery. As a result of this, my subjects
had significantlylower preoperativeblood pressure when compared 3-
years postoperatively.In addition, the subjects in my study were 3
years older compared to the time when surgerywas performed. As
discussed earlier, their attending physiciansmay have had taken a more
liberal approach with theirantihypertensive treatment due to the fact
that the patients were older, abiding by the notion that blood pressure
increases with age. Perhaps a reexaminationof Engblcm's study
groups at 3 years post would also revealed a significantincrease in
blood pressure.
In mystudy, pre CABG blood pressure measurementswere extracted
fromchart review. These one-time blood pressure measurements may
be not representative of the subjects' usualdaily blood pressure in the
periods prior to their CABG surgery. Furthermore, I could not ascertain
"
that these blood pressure measurements were done in a standardized
fashion as the way how it was performed 3 years post CABG surgery.
This is certainly a downfall in studies with retrospective design such as
this one. This limitationwill be discussed later in this thesis.
Anyhow, it is disappointingto see that approximately half of the study
subjects (46.2%) continued to have systolic blood pressure 2:: 140
mmHg and more thanhalf of subjects (53.8%) have diastolic blood
pressure 2:: 90 mmHg 3 years after CABG surgery. One important
factor thatmay have contributed to these findings include a higher
proportion of subjects not on any antihypertensive medication at 3
years post CABG surgery (11.5%) compared to the pre CABG
subjects (1.7%). The proportion of subjects on 3 to 4 antihypertensive
medication were alsolower (15.4%) pre CABG comparedto 13.5% 3
years post CABG surgery . However, having said that. the mean
systolic blood pressure of 135.0 rnmHg and mean diastolic blood
pressure of85 .3 mmHg were well within the respectable target of
treatment among the post-CABG subjects.
76
4.1.3 Body Mass Index
In my study, a significantincrease in body mass index (BMI) was
detecteddespite an increase in the proportionof overweightsubjects
receiving weight reduction and diet modificationcounseling post-
CABG surgery. The reason for this increase in BMI post-CABG
surgery was likely to bemultifactorial. Chart review of documented
weight reduction & diet counseling/referralmay bean underestimation
of the actual amountof advice subject received prior to their surgery.
Advice from familymembers and friends were almost never
documented in the subjects ' chartsand therefore not available during
chart reviews. Furthermore, physicians' progress notes were many
times summarizedand may not reflect the actual consultationthat took
place between the physiciansand the subjects. In addition to that.
subjects' files at the private clinics outside of the Health Science
Centre were not reviewed. With improved symptomotology post
CABG surgery, both the subjects and their healthcare provider may
have taken a more lenientapproach to risk factors modification.When
n
these factors were taken into consideration,I believe that the amount of
diet modificationand weight reduction counselingsubjects received
may well be unchangedpro and postCABO surgery. In short. it
appeared in my study that counselinghad not been effectivein
reducing the proportionof overweight subjects possibly due to the
factors mentioned above.
There could beother compoundingfactors that could have affected
subjects' BMI pre and post operatively. One of such factors include a
probable more aggressive use of diuretic agents as antihypertensive
agents that could result in lower weight among the subjects
preoperatively. The data specifically on diuretics usage was not
collected in this study. Future studies with larger sample size that takes
into account the use of diuretic agents would be useful to assess the
modificationof BMI among the post CABO population. Other factors
that could have affected the BMI amongthe study subjects include an
increased age among the subjects and a somewhat lower levels of
activities (as discussed earlier) 3 years post CABO surgery.
4.1.4 Cigarette Smoking
There was clinically significant change foundin the smoking habits of
subjects at 3 years post CABGsurgery in this study. One thirdof
smokers stoppedsmoking3 years post CABG surgery. Even among
smokers, they were smokingone fewer cigarettescomparedto pre
CABG periods. This is consistentwith a prospective cohort study by
Allen JK & BlumenthalRS 31 that showed a significant decrease in
smoking habit at 6 monthsafter CABGsurgery. On the contrary.
studies by EngblomE, et al. 39 and Allen JK et al. soshowedthat there
was no significantdifference in the smokinghabits of patients who
were randomized into the special interventiongroup that receive
additional interventionon coronary risk factor modificationcompared
to the usual (control) group at 12 months post CABG surgery.
In my study, there were only 12 subjects who were cigarette smokers
prior to their CABG surgeries. Four out of these 12 subjects had
stopped smokingfollowing their CABG surgery. Given the small
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number of smokersin my study, it is difficultto cometo a finn
conclusion withregardsto smokinghabit of subjects3 years post
CABG surgery.
4.1.5 Exercise l.&vels
Results fromthe questionnaires showed that 57.7% of subjeets are
physically exercisingmoreat 3 years post CABG surgerycompared to
the period prior to their CABG surgeries. Nineteen point two
percentage of subjects reported that theywere exercising less
compared to their activitiesprior to CABG surgerywhile 23.1% of
subjects denied any change in their exercise activities before and after
CABG surgery .
so
4.2 Impact of Cardiac Rehabilitation Program
Intensiverehabilitation programswere used in past studies to assess if
coronary risk factorscan be better managed in patientswith llID. However,
there is evidence that usualpostoperative care is no less effective thanan
intensive rehabilitationprogramin modifying certain coronary risk 39 40.
Modifying behavior such as smoking cessation, even if successful, was only
effective in the short term at best while subjects were still actively
participating in the programsthat usuallylasted for approximately1 year.
Long term results were less convincing. 00 the contrary, other studies 3840
showed that certainrisk factors such as total cholesterol and smoking habit
improved even under normalpostoperative care. Therefore, there is little
advantage to the implementationof a specialrehabilitationprogram for
CABG compared to the existing one at this point. This studyshowed that
only a small percentage (19.2%) of the S2 study subjects bad undertaken the
cardiac rehabilitation programafter their CABG surgery. Our emphasis now
should be a more efficient utilization of our existing cardiac rehabilitation
programuntil we have more convincing evidence on the effectiveness of the
81
previouslymentionedshort termedintensiveprograms.Nevertheless,these
speciallydevisedrehabilitationprogramsundoubtedlypaved the way for
futurestudies.
4.3 Impactof Support Network
Of a total of 52 subjects studied,most subjects (84.6%)reported that they
had one or more familymembers, friends, andlorhealthcare workerswho
gave them supportin controlling subjects' coronaryrisk factors. This finding
is not surprisingconsidering the possible indirect effects of the current public
healthstrategies with widespread dissemination of information relatedto
heart disease and its preventionthroughthe media. This is particularlytrue
with regard to approaches to increasing awareness of the detrimental effect of
cigarettesmoking. It is disappointingto see that even this levelof social
supportfoundin this studybad not resulted in a greater improvement in
coronaryrisk factorsspecificaly smoking cessation.
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4.4 Limitationsand Strengthsof the Study
4.4 .1. Limitations of Study
One major limitationof this study was the smallsample size avai lable
for the before and after comparisons of risk factorsmodification.
Althoughthe nwnber of study subjects was large enough
mathematically to draw conclusionson risk factors such as total
cholesterol, bloodpressures, and BMI, it was unable to provide
meaningfulresults on the other important lipid stratifications such as
HDL and WL as well as smokinghabit amongthese subjects. From
the calculations executedfor all 4 majorcoronaryrisk factors, the most
conservative estimateto ensure adequate studypopulationwas 199
subjects. This is due to the fact: that a large sample size is needed in
detectinga smallchange such as in HDL levels. As an example, in
order to detect a 0.1 (10%) change in HDL cholesterolwith &=0.5, a
sample size of;:: 199subjects was needed to achievestatistically
significance of a==O.OS with80% power.
"
Had a larger sample size been enrolled.calculationof risk ratio
(division of total cholesterolby HDL) couldhave beenpcrfonned to
better assess coronary risk factor and its changeover the 3-year period .
A large sample size study also allows multivariateanalysis to be
carriedout to assess modification of a singlerisk factor at a time while
stratifying the other risk factors.
There are several possible strategiesthat could have been undertaken
to improvecompliance amongrespondent and thus enrollmentfor this
study. From the experience I had, many subjects declined participating
in the study for the interviewsmainlybecause of time constraints and
inconveniencewith transportationto the hospital. For the purpose of
future investigations,perhaps a "house call" method of subject
interview and risk factors measurementwould potentiallysolve the
problem with small sample size in this study. However, this translates
to greater use of resources as the investigator would be required to
travel to subjects' residence to perform the interviewprocess, measure
subjects' height, weight, blood pressure, and perform venepuncture for
laboratory investigations. Portablemeansof riskfactormeasurements
would then be required suchas the portablesphygmomanometer, hlood
collection kit, and a portablescales andmeasurement tape for height.
With these strategiesin place, I believethe number of enrollmentfor
the studywouldbe greatlyincreased.
It is well knownthat subjectswho refusedto participatein the study
may do worse with regardsto coronaryrisk factorsmodification
comparedto patientswho participatedin the study. This is related to
participants'likelihood of highercompliancewith interests in
healthcareproviders' suggestionsor advicewith regards to health
status . Takinginto accountthese factors, the resultsof risk factor
modificationfrom this studycouldbe overestimated.
As previouslymentioned, retrospectivechart collectionof pre CABG
bloodpressuremay not be representativeof subjects' usual blood
pressureprior to the surgery.Thiswas certainlynot done in a
standardizedfashion that can be reproduced in the methods of blood
ss
pressure measurements 3 yearspost CABGsurgery. This similarly
applies to fastinglipid profileswherebythe fastedhourswere unknown
and that the resultscamefrom different laboratories wherethe blood
sampleswere sent to. Subjects' weightand heightmeasurements pre
CABG surgerymaynotbe performedin a uniformed mannerin light
clothingwithshoes removed. Thevalidity of this values and thus the
results of this studycould be increasedhad these pre CABG
measurements were consistent and standardized using a prospective
study design.
An observer biascouldhavebeenreducedby the use of a randomzero
sphygmomanometer as replacementof clinicalmercury
sphygmomanometer for the measurementof arterial bloodpressure.
This wouldpotentiallyreduce biason the pan of the investigatorwho
mayhaveknowledgeof subjects' risk factorsparametersprior to
measuringtheir arterial bloodpressures. In addition.corroboration of
smokingstatus usingan Ecolyzerbreathtest couldhave been usedto
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potentiallydecrease bias. Neither of these apparatuswas available in
this study.
4.4.2. Strengths of Study
Persons who were diagnosed with a life threateningillness (i.e.,
malignancy)not related to coronary artery disease within 6 months post
CABG were excludedfrom this study. This is because it was estimated
that the long term benefit of coronary risk factors modification may no
longer have been a priority in this particular group of subjects. This
strategy had hopefullyreduced bias that could have resulted in lower
risk factor modification in this study sample.
A standard study questionnaire was used to effectively reduce the
potential bias in having the subjects interviewed by the principal
investigator who knew about the history of the patients. Without
standard questions, the principal investigator may have unintentionally
promptedor searchedmore diligently for a particular risk factor.
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However, data collection viaquestionnaire may provideweaker
evidence as self reports are subjective measurements.
Other than the subjects and their immediate care physicians, no other
party was informedof theirparticipation of this study. Contact of the
physicians of subjects who participated in the study was done just prior
to asking subjects to take part. This should have prevented the possible
bias caused by a heightened attention given to the patients enrolled in
the study with regards to coronary risk factor modification. One of the
major strengths of this study design is minimization of a Hawthorn
effect. The results of the lipidprofiles were subsequently sent to
subjects' Individual physicians.
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Chapter 5. Summary,Conclusionsand Implications
5.1 S!!!:nmID'
Many coronaryriskfactors remained unimproved3 years after CABG
surgery. This was particularlytrue of hypertension,obesity, and
smoking cessation. In fact, arterial blood pressures and BMI had
worsened significantlydwing the 3 years post CABG period. Even so,
the mean blood pressures of 135 mmHgsystolicand 85 mmHg
diastolic were good treatmenttarget for this groupof subject 3 years
post CABO surgery. Results for BMI were rather disappointing
consideringonly slightmore thanhalf of subjects (57.8%) who were
obese with BMI > 25 KglM2report ed that they had received advice or
counseling on weight reduction during the 3 years period post CABG
surgery. There wasno significant decrease in smokinghabit 3 years
after surgery even though most smokers (87.5%) admitted to have
receivedadvice or counselingwith regards to smoking cessation.
Hyperlipidemiareceived appropriate intervention as it saw a significant
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decrease in total cholesterol and LDLlevels at 3 years post CABG
surgery.
This study also revealed that approximately 58% of subjects were
physicallyexercising more comparedto the period prior to their CABG
surgery eventhough only a minority (19.2%)of the subjects had
undertakenthe cardiac rehabilitationprogrampost CABG surgery.
There seemedto be a strong support social network.aroundthe
subjects studiedas most of them(84.6%) reported to have at least one
person in helping them to monitor their coronary risk factors.
5.2 Conclusions and Implications of Study
According to the results of this study, current health care strategies in
secondary prevention of coronaryheart disease have only been
partiallysuccessful.particularlyin serum lipidmodifications.
Regardless of the apparentbeneficialeffects of lowering serumlipid
levels, suchbenefitsare much less apparent ifmodification of other
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coronary risk factors is not also achieved. Efforts must now focus on
cessation of smoking, reduction of body weight, and normalizationof
high bloodpressure. With these secondary preventative strategies in
controlling atherosclerosis. the future impactwill likelybe of great
importance in substantially diminishing the rate of acute cardiac events
and subsequently reducing the overall health care cost. With economic
forces focusing on reducing costs while we attempt to secure access of
everyone to quality medical care. one of the most urgent priorities in
our medicalcare system should be preventionof heart and vascular
disease as an alternativeto increasingly expensive treatments for
established disease.
However compelling the data are on the benefit of secondary
prevention of coronaryheart disease, major coronaryrisk factors such
as smoking cessation and BMI are not being modifiedto meaningful
levels. A detailed analysisof our preventativehealthcare system is
essentialin understanding this deficit. Risk factor modificationcannot
readilybe grafted onto a system focused on acute care encounters. I
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believe that mostof the failureto achieverisk factormodification in
practice can be traced to the sttuetura1 inadequacyof the acute care
encounteras the basis for management.Physicians' successin
facilitatingthis processis generally quitelimited.In Part.this is due to
a lack of physiciantime during hospitalization or during increasingly
brief outpatient encounters. Moreover.risk factormodification may
receive a lower priority fromphysicians,who maypreferentialy attend
to acute problems. Perhapsthere is a place for a specializednurse
trainedin modifying coronaryrisk factors with aggressive longterm
followup in our system.
Finally,physiciansmayexperience less professional and financial
reward fromprevention thanthey do fromtreatment. Although
provincialhealthinsurance varies acrossCanada,financial
reimbursement for risk factormodificationsis generallylimited to only
regularoffice visitfee schedulewhereas treatments such as
cryotherapy of plantarwarts. vaccination, and psychotherapy
counseling can be readilyincorporatedintoa visitwith additional
"
remuneration to physiciansin our existing health care services.
Furthermore, eventhoughpreventivecare has becomea watchword in
the health care reformagenda, relatively smallereffortor
reimbursementflows to preventivetreatment (e.g., smoking cessation)
as opposed to screening(e.g. mammography).
Perhaps behaviouralprinciplesmay be moreefficientthanthe more
commonly used cognitive reasoning as a basis for coronary risk factors
modification. With heavy mediaand public awareness programs
currentlyin place, most patients may already understan d the impactof
these factorson theirhealth . To changetheir behaviour,however,is
anotherchallengeof its own. A rich literatureexists on the behavioral
principlesrequired to effectrisk factor modificationSl S2. One of the
most important behavioralprinciplesunderlyingeffectiverisk factor
modificationis the need for multi-eomponent programsand multiple
encountersprovidedover an extendedperiod. Perhaps the achievement
of cigarette smokingcessation in one thirdof smokers in this study is a
resultof such endeavors.
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This study showed that most overweight individuals received
counseling with regards to weight reduction(57.8%) and diet
modification(62.2%) respectively fromhealth care professionals
during the 3 years post CABG period. Yet, there was no significant
change in the percentage of overweight subjects during the 3 years post
CABG surgery period. I believe that there are other factors that limit
the implementation of risk factors modificationother than sole
responsibilityon the part of our health care providers. Patient
compliancewith adherence to lifestyle modifications will continue to
be a major issue in our health prevention programtoday as will cost of
medications.
Successful implementations of secondary preventionof coronary heart
disease may requiremore complex interventions. Further research is
warrantedin this area. Outcomedata from various cardiac
rehabilitationprogramsmight stimulate more successful prevention
implementationstrategies.
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APPENDIX Ia
SubjectsIdentification ForCABGStudy
Extraction of data fromCABOOperation Patients'ListingSchedule&
MedicalRecords
1. Name
2. Sex
3. Age(DOB)
4. Health insurance number
5. Address
6. Phone number
7. Family doctor
8. Attending physician
9. Dateof surgery
10. CABGas secondary concomitant
procedure {e.g. valvesurgery as
primary procedure) Y IN
I I. Repeat CABGsurgery YI N
12. Diagnosed life threatening illnesses
within6 months postCABG
(e.g. malignancy) Y IN
Specify
'03
Appendix Ib
ChanReviewPre-CABG Surgery
Extraction ofData from Department of Medical Records
RiskFactors Prior to CABGsurgery:
13. Smoking status cigslday
14. Blood pressure _ _ _ I_ _ _ mmHg
IS. Weight kg
16. Height m
17. Fasting serum lipidprofile Photocopy
18. Adviceon weightreduction Y IN
19. Adviceon dietmodification/dietitianconsultation YIN
20. Advice on smokingcessation
21. List of Medications
'04
Photocopy
Y I N
Appendix Il
An investigation of risk factor modifications
after coronaryarterybypasssurgeryin Newfoundland
Subject Interviewand Assessmentat 3-Years FollowUp
First. I would like to ask you some questions about your medicalhistory .
1. Have you had a heart attacksinceyour first bypasssurgery?
YesINo
If the answer is yes, can youplease give me the number ofattacks?
and the date(s) of the attack(s)?
2. How many bypass surgeries have you had?
What is(an:) the date(s ) of your bypass surgery(ies)?
DDIMMiYr
3. Have you had a dye test (coronary angiography) since your first bypass
surgery?
If the answer is yes, indicate the nwnber oftest(s)
and the date(s) of the dye teSl(s)
4. Have youparticipatedin any fonn of cardiac rehabilitationprogramsince
your firstbypass surgery?
YeslNo
How many cardiac rehabilitation programs have you attended?
""
Where waslwere the program(s) held? _
S. Have you been admitted to the hospital since yourfirstbypasssurgery?
Yes!No
Iftbe answeris yes pleaseindicate the
Reasons: Dates:
1. _
2. _
3. _
4. _
6. Haveyoubeendiagnosedof anyother diseases since yourfirst bypass
surgery? (e.g. cancer, renalfailure. andetc)
YesINo
If the answer is yes, please indicate the:
Disease(s)
1. _
2. _
3. _
4. _
Date(s)of diagnosis
Now I wouldliketo asksomequestions aboutyourrisk factorsforcoronary
artery disease.
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7. An: you a:
former smoker
non-smoker
Please gato 7.1
Please go to 7.2
Please go to question 8.
7.1 Ifyou are a current smokerplease indicate ifyou smoke:
(please tick only one)
I - 9 cigarettes/day
10 - 20 cigarettes/day
More than 20 cigarettes/day
7.2 Ifyou are a formersmokerplease indicatewhenyou stopped
smoking .
Date:
7.3 Haveyou tried to stop smoking yourselfsinceyour first bypass
surgery?
YesINo
If the answer if yes please indicate how manytimesyou have tried to
stop smoking yourself.
Whenwasthe last time you smoked?
DD,MMlYY
7.4 Haveyou attendedanysmoking cessation programssince your first
bypass surgery?
Yes/No
167
If the answer is yes please indicatewhere this is a: Tickoneor more
physician initiatedpcoc':ss_ (e.g. referral by a doctor)
self initiatedprocess_
others (pleaseexplain)_
How many times have you attended the smokingcessationprograms
since your first bypass surgery?
Where was/werethe smokingcessation program(s)held?
When waslwere the smokingcessationprogram(s)held?
7.5 Haveyou received anyform of advice or cmmselingwith regards to
smokingcessationsince your first bypass surgery?
YesINo
If the answer is yes please indicate if the counseling or adviceco me
from: (Tickoneor more)
family doctor
heart specialistdoctor
smokingcessation program
others (please explain)
How manytimes have you received advice or counseling with regards
to smokingcessation by your doctor or the staff from the smoking
cessationprogram since your first bypass surgery?
108
When did you last receivedadvice or counselingwith regardsto
smoking cessationsinceyour first bypass surgery?
8. Hasa doctor ever diagnosed you of having diabetes mellitus?
Yes!No
If the answer is yes please indicateyour usual blood glucose levels for
the last one month
When wen: you diagnosed ofhaving diabetes mellitus?
9. Haveyou received any form of advice or counselingwith regards to
diet modificationsince your first bypass surgery?
YesINo
If the answer is yes please indicate if the counselingor advice comes
from: (Tick one or more)
family doctor
heartspecialist doctor
dietitian
otherstpleaseexplain)
'09
How many times have you receivedadvice or counselingfrom your
doctor or your dietitianwith regards to diet modificationsince your first
bypasssurgery?
When did you last receivedadvice or counselingwith regards to diet
modification since your first bypass surgery?
In your opinion, have you modifiedyour diet intakesince your first
bypass surgery?
YesINo
Are you currently taking any dietary supplements?
YeslNo
Ifyes, please indicate ifyou take one or more oftbe following:
(Tick one or more)
fish oils
seal oils
eelerytablets
10. Haveyou receivedany form of advice or counselingwith regards to
weightreductionsince your firstbypass surgery?
YeslNo
If the answer is yes please indicate if the counseling or advice comes
110
from: (Tick one or more)
family doctor
heart specialistdoctor
weight reduction program
others(please explain)
How many times haveyou received advice or counseling fromyour
doctor or the staffs from the weight reduction program with regards to
weight red uction since your first bypass surgery?
Whendid you last receivethe adviceor counse ling wi th regardsto
weight reduction?
DDIMMIYY
11. In your opinion. do you exercise : (please tick one only)
more__since your bypass surgery
less__ since your bypass surgery
no difference__since your bypass surgery
12. How many family members . friends. relatives. and healtbcare
worker were helping you in controlling your coronary risk factors (i.e.
stopping smoking. diet modification, controlling your blood pressure.
encouragin g you to exercise, and weight reduction) since your bypa ss
surgery?
13 list all current medications in the space below .
III
Appendixfil
7·DAY ACTMTYRECALL
Now we would like to know about your physical activity during the past 7
days. Butfirst Jetme ask you about your sleep habits.
1. On the average. how many hours did you sleep each night during the last five
we<I«Ioy mghu (Sunday-Thunday)?
2, On the average, how many hours did you sleep each night last Friday and Saturday
nights?
Now, I am going to ask you about your physical activityduring the past 7 deys, that is,
the last 5 wtekda~ and last weekend, Saturdayand Sunday. We ere not going to talk
abou1light activities such IS slow walking, light housewod., or unstrenuous sports such
as bowling. archery , or softball. Please look 81this list which show s some examples of
what weconsider moderate, hard, and very hard activities. (Interviewer: hand subject
Appendix VI andallowtimefor the subjectto readit over.)Peopleengagein manyother
types of activit ies. and if you are not sure where one of your activities fhs,p~ ask me
about it.
J . First, let's consider modcme aai viti cs. What activities did youdo and bow many total
boun did you spend duringthe last 5 weekdaysdoing these moderate activitiesor
others like them? Please tell me to the nearest halfhour.
4. LastSaturday and Sunday, how many hours did you spend on moderate activities and
what didyoudo?(Probe: Canyouthink orany other sports. job. or household
activities thatwould fit into this category?)
s . Now, let's look at hard activities. What activities did you do and how many totalboon
did you spend during the last S weekdays doing these hard activities or others like
them? Please tell me to the nearest half hour.
6. Last Satuniayand Sunday, bow many hoursdid you spend on bud activities and what
did you do?(Probe : Can you think of any other sports.,job, or household activities that
III
houn
7. Now, let's look at very hard activities. Wha t activities did you do and how many total
hours did you spend during the last 5 weekdays doing these very hard activities or
others like them? Please ten me to the nearest half hour.
houn
8 LastSaturday and Sunday, how many boon did you spendon very hard activities and
what did you do? (Probe : Canyou think of any other sports, job, or bousebokf
activities that wouldfit imo this categ~)
houn
9. Compared with your physical activity over the past 3 months, was last week's
physical activity more, less, or about the same?
1. More
3. About the wnc:
Interviewer: Please list below any activities reported by the subject which you don't
know how to classify. Flag this record for review and completion.
Activity (brief descript ion) Hours: workday
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Hours: weekend day
Occupational tasks
Household activities:
Sports activities:
(actual playing time)
Appendix IV
Examples of Activities in Each Category
ModerateActivities
1. delivering mail or patrolling on foot
2. house painting
J. truck driving (making deliveries, lifting and carrying
lightobject5)
I . raking the lawn
2. sweeping and mopping
J . mowing the lawn with a power mover
4. cleaning windows
I . volleyball
2_Ping-Pong
J . brisk walking for pleasureor to work (4.8Jkmlhour (J
mileslbour) or 20 mirwteslkm(mile»
4. golf, walking and pulling or carrying clubs
5. calisthenic exercises
Occupational tasks:
Household tasks :
Sports activities:
(actual playing time)
Occupational tasks
Household tasks:
Sports activities
(actual playing time)
HardActivities
1. heavy carpentry
2. constructionwork, doing physical labor
1. scrubbing floors
1. tennis doubles
2. disco. squareor folk dancing
VeryHardActivities
1. very hard physical labor. digging or chopping with heavy
tool,
2. carrying heavy loads such as bricks or lumber
1. shoveling snow,
I . jogging or swimming
2. singles tennis
3. racquetball
4. JOCCer or ice hockey
n



